Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Medical Devices Regulations

Version of section 61.4 from 2021-12-23 to 2023-02-21:

  •  (1) The holder of a medical device licence shall prepare

    • (a) in the case of a Class II medical device, on a biennial basis, a summary report of the information that pertains to the matters referred to in subsection (2) and that the licensee received or became aware of during the previous 24 months; and

    • (b) in the case of a Class III or IV medical device, on an annual basis, a summary report of the information that pertains to the matters referred to in subsection (2) and that the licensee received or became aware of during the previous 12 months.

  • (2) The matters to be covered by the summary report are

    • (a) adverse effects;

    • (b) problems referred to in paragraph 57(1)(a);

    • (c) incidents referred to in subsection 59(1); and

    • (d) serious risks of injury to human health that are relevant to the safety of the medical device and are referred to in subsection 61.2(2).

  • (3) The summary report shall contain a concise critical analysis of the information referred to in subsection (1).

  • (4) In preparing the summary report, the licensee shall determine, on the basis of the analysis referred to in subsection (3), whether what is known about the benefits and risks associated with the medical device has changed as described in any of the following paragraphs:

    • (a) any of the benefits that may be obtained by patients through the use of the medical device could be less;

    • (b) in respect of any of the risks,

      • (i) the risk is more likely to occur, or

      • (ii) if the risk occurs, the consequences for the health or safety of patients, users or other persons could be more serious; and

    • (c) a new risk has been identified.

  • (5) The licensee shall include the conclusions they reach under subsection (4) in the summary report.

  • (6) If, in preparing the summary report, the licensee concludes that what is known about the benefits and risks associated with the medical device has changed as described in any of paragraphs (4)(a) to (c), they shall notify the Minister, in writing, within 72 hours after having reached the conclusion, unless that has already been done.

  • SOR/2020-262, s. 16

Date modified: